Kheiron's first solution is our award winning AI breast screening solution, Mia™. Mia™ offers a simple case-wise suggestion aligned to the actual critical clinical decision a radiologist has to make: to recall or not to recall a woman for further evaluation. Mia™ has already received CE marking, having demonstrated state-of-the-art performance in an independent, multi-center clinical study in Europe.
The results indicate that Mia™ exceeds the recommended US performance benchmarks for breast screening radiologists. Kheiron Medical Technologies has been awarded multiple grants to support advanced clinical trials of Mia and live deployments across the NHS in England and in Scotland in early 2020. In the US, we are conducting pre-commercial pilots and clinical studies of Mia™ with world leading academic medical centers and independent diagnostic imaging providers.
Date of establishment：2016/1/1
Fundraising round：A roundWebsite address
Diagnosing cancer is an extremely challenging and time-consuming task, even for the most experienced…more...
Contact person：Helen MacBain
CEO and co-founder
CTO and co-founder
Chief Strategy Officer
Chief Commercial Officer